QNB CORP.·4

Feb 18, 3:07 PM ET

Mcdonald Christina 4

4 · QNB CORP. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

QNB CORP. EVP Christina McDonald Receives Stock Award

What Happened Christina McDonald, EVP and Chief Marketing Officer of QNB CORP. (QNBC), was granted a total of 1,500 shares as restricted stock awards on February 13, 2026. The awards were issued at $38.00 per share in four entries (750 shares and three separate 250-share derivative awards), with a combined value of approximately $57,000. These were awards/grants (code A) — not open-market purchases or sales — and are compensation-related rather than indicative of an immediate buy/sell decision.

Key Details

  • Transaction date: 2026-02-13; Filing date: 2026-02-18.
  • Grants: 750 shares @ $38.00 (acquired) + three derivative grants of 250 shares @ $38.00 each — total 1,500 shares; aggregate value ≈ $57,000.
  • Transaction code: A (award/grant). Footnote F1: Restricted Stock Award.
  • Shares owned after transaction: Not specified in the filing.
  • Timeliness: The Form 4 was filed five days after the transaction (Feb 18 vs Feb 13). SEC Form 4s are typically due within two business days, so this filing appears to be outside the usual window.

Context The derivative entries and footnote indicate these are restricted stock awards (likely subject to vesting and transfer restrictions), not immediate option exercises or open-market trades. Restricted awards are compensation and do not necessarily signal short-term insider buying or selling intent. As always, awards are common for executive pay and should be considered alongside other insider activity and company fundamentals.

Insider Transaction Report

Form 4
Period: 2026-02-13
Mcdonald Christina
EVP Chief Marketing Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-13$38.00/sh+750$28,500935 total
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2026-02-13Exp: 2036-02-13Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2027-02-13Exp: 2036-02-13Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2028-02-13Exp: 2036-02-13Common Stock (250 underlying)
Holdings
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2024-02-15Exp: 2033-02-15Common Stock (200 underlying)
    200
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2025-02-15Exp: 2033-02-15Common Stock (200 underlying)
    200
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2026-02-15Exp: 2033-02-15Common Stock (200 underlying)
    200
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2027-02-15Exp: 2033-02-15Common Stock (200 underlying)
    200
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2028-02-15Exp: 2033-02-15Common Stock (200 underlying)
    200
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2025-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2026-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2027-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2028-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2029-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2026-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2027-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2028-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2029-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2030-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
Footnotes (1)
  • [F1]Restricted Stock Award
Signature
Christina S McDonald|2026-02-13

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT